Motokuni Aoki

8.2k citations

122 papers · 6.7k indexed · 1 hit paper · h-index 49

Molecular Biology top 2%
Surgery top 1%
Cardiology and Cardiovascular Medicine top 2%
Hepatology top 1%
Cancer Research top 2%

Co-authors: Ryuichi Morishita Toshio Ogihara Yasufumi Kaneda Yoshiaki Taniyama Kunio Matsumoto Jitsuo Higaki Hironori Nakagami Naotaka Hashiya
Topics: Liver physiology and pathology (30 papers)Angiogenesis and VEGF in Cancer (16 papers)Organ Transplantation Techniques and Outcomes (16 papers)
Cited by: Hepatology Cancer Research Molecular Biology
Journals: Circulation Nature Medicine Circulation Research
Partner nations: Japan France United States

In The Last Decade

Motokuni Aoki

119 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

1997 521 citations Ryuichi Morishita, Motokuni Aoki et al. profile →

Peers

Countries citing papers authored by Motokuni Aoki

Since Specialization

Citations

This map shows the geographic impact of Motokuni Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motokuni Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motokuni Aoki more than expected).

Fields of papers citing papers by Motokuni Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motokuni Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motokuni Aoki. The network helps show where Motokuni Aoki may publish in the future.

Co-authorship network of co-authors of Motokuni Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Motokuni Aoki. A scholar is included among the top collaborators of Motokuni Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motokuni Aoki. Motokuni Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Moxibustion Promotes Formation of Granulation in Wound Healing Process through Induction of Transforming Growth Factor-β in Rats 2019 ·Chinese Journal of Integrative Medicine ·(unknown),Hirohisa Kawahata,(unknown),Motokuni Aoki	9
2	Novel Strategy of Gene Therapy in Cardiovascular Disease with HVJ-Liposome Method 2015 ·Contributions to nephrology ·Ryuichi Morishita,Jitsuo Higaki,Motokuni Aoki,Shinichiro Hayashi,Iwao Kida,Yasufumi Kaneda,Toshio Ogihara	0
3	The role of gerontology in the era of a super-aged society 2014 ·Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·Toshio Ogihara,Motokuni Aoki,Hiromi Rakugi	0
4	Model of Vasculogenesis from Embryonic Stem Cells for Vascular Research and Regenerative Medicine 2006 ·Hypertension ·Hironori Nakagami,(unknown),Yasushi Takeya,(unknown),(unknown),Shinichiro Hayashi,Motokuni Aoki,Kunio Matsumoto,Toshikazu Nakamura,Toshio Ogihara,Ryuichi Morishita	27
5	Clinical Trial of Human Gene Therapy Using Hepatocyte Growth Factor Gene Transfer(Translational Research in Cardiovascular Disease, The 69th Annual Scientific Meeting of the Japanese Circulation Society) 2005 ·Japanese Circulation Journal-english Edition ·Motokuni Aoki,Ryuichi Morishita,Hirofumi Makino,Naotaka Hashiya,(unknown),Yasushi Takeya,Hitomi Kurinami,Toshio Ogihara	1
6	A calcium‐channel blocker, benidipine, improves forearm reactive hyperemia in patients with essential hypertension 2005 ·Blood Pressure ·Hirofumi Makino,Motokuni Aoki,Naotaka Hashiya,Keita Yamasaki,Hideo Shimizu,Ken Miwa,Toshio Ogihara,Ryuichi Morishita	7
7	Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor 2004 ·Journal of Human Hypertension ·Kazuhiko Yamasaki,Motokuni Aoki,Hirofumi Makino,Naotaka Hashiya,Hideo Shimizu,Mitsuru Ohishi,Toshio Ogihara,Ryuichi Morishita	7
8	HVJ-envelope vector for gene transfer into central nervous system 2003 ·Biochemical and Biophysical Research Communications ·Munehisa Shimamura,Ryuichi Morishita,Masayuki Endoh,Kazuo Oshima,Motokuni Aoki,Satoshi Waguri,Yasuo Uchiyama,Yasufumi Kaneda	39
9	Effective transfection of a cis element “decoy” of the nuclear factor-?B binding site into the experimental choroidal neovascularization 2002 ·Current Eye Research ·Nobuo Jo,Nahoko Ogata,Motokuni Aoki,Tsuyoshi Otsuji,Ryuichi Morishita,Yasufumi Kaneda,Miyo Matsumura	6
10	Impairment of collateral formation in Lp(a) transgenic mice : Therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene 2002 ·Japanese Circulation Journal-english Edition ·(unknown),Ryuichi Morishita,(unknown),Yasufumi Kaneda,Motokuni Aoki,Toshio Ogihara	1
11	Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin I2 analogue 2002 ·Journal of Endocrinology ·Kunio Matsumoto,Ryuichi Morishita,Naruya Tomita,A Moriguchi,Keiko Yamasaki,Motokuni Aoki,Teruya Nakamura,Jitsuo Higaki,Takeshi Ogihara	25
12	Therapeutic angiogenesis induced by HGF gene in rat diabetic hind limb ischemia model: Molecular mechanisms of delayed angiogenesis in diabetes. 2001 ·Japanese Circulation Journal-english Edition ·Naotaka Hashiya,Motokuni Aoki,(unknown),Kazuya Hiraoka,Tatsuo Ogihara,Ryuichi Morishita,Yasufumi Kaneda	2
13	Decoy Oligodeoxynucleotides As Novel Cardiovascular Drugs for Cardiovascular Disease 2001 ·Annals of the New York Academy of Sciences ·Ryuichi Morishita,Motokuni Aoki,Yasufumi Kaneda	18
14	Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice 2001 ·Journal of Hypertension ·Masahiro Akishita,Gotaro Shirakami,Masaru Iwai,Lan Wu,Motokuni Aoki,Lunan Zhang,Kenji Toba,Masatsugu Horiuchi	17
15	Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease 2001 ·Gene Therapy ·Yoshiaki Taniyama,Ryuichi Morishita,Motokuni Aoki,Hironori Nakagami,Kei Yamamoto,Koji Yamazaki,Kunio Matsumoto,Takashi Nakamura,Y Kaneda,Toshio Ogihara	175
16	In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model 2000 ·Gene Therapy ·Katsuhiko Hayashi,S. Nakamura,Ryuichi Morishita,A Moriguchi,Motokuni Aoki,Kunio Matsumoto,Teruya Nakamura,Y Kaneda,Noboru Sakai,Toshio Ogihara	69
17	Gene Therapy for Cardiovascular Disease Using Hepatocyte Growth Factor 2000 ·Annals of the New York Academy of Sciences ·Ryuichi Morishita,Motokuni Aoki,Shigefumi Nakamura,Jitsuo Higaki,Yasufumi Kaneda,Toshio Ogihara	9
18	Transcription factor decoy for nuclear factor-κB inhibits tumor necrosis factor-α-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells 1998 ·Journal of Hypertension ·Naruya Tomita,Ryuichi Morishita,(unknown),Kei Yamamoto,Motokuni Aoki,Hidetsugu Matsushita,Shinichiro Hayashi,Jitsuo Higaki,Toshio Ogihara	59
19	Inhibition of intimal hyperplasia after vein grafting by in vivo transfer of human senescent cell-derived inhibitor-1 gene 1998 ·Gene Therapy ·Hong-zhi Bai,Ryuichi Morishita,Iwao Kida,Tomoyuki Yamakawa,(unknown),Motokuni Aoki,Hidetsugu Matsushita,Asao Noda,R Nagai,Y Kaneda,Jitsuo Higaki,Toshio Ogihara,Yoshiki Sawa,Hikaru Matsuda	40
20	Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the β-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area 1997 ·Gene Therapy ·Motokuni Aoki,Ryuichi Morishita,Jitsuo Higaki,A Moriguchi,Shusaku Hayashi,Hidetsugu Matsushita,Iwao Kida,Naruya Tomita,Yoshiki Sawa,Y Kaneda,Toshio Ogihara	30

About Motokuni Aoki

Motokuni Aoki is a scholar working on Hepatology, Cancer Research and Immunology and Allergy, having authored 122 papers that have together received 6.7k indexed citations. Recurring topics across this work include Liver physiology and pathology (30 papers), Angiogenesis and VEGF in Cancer (16 papers) and Organ Transplantation Techniques and Outcomes (16 papers). The work is most often cited by research in Hepatology (897 citations), Cancer Research (887 citations) and Molecular Biology (3.0k citations). Motokuni Aoki has collaborated with scholars based in Japan, France and United States. Frequent co-authors include Ryuichi Morishita, Toshio Ogihara, Yasufumi Kaneda, Yoshiaki Taniyama, Kunio Matsumoto, Jitsuo Higaki, Hironori Nakagami, Naotaka Hashiya, Toshikazu Nakamura and Keita Yamasaki. Their work appears in journals such as Circulation, Nature Medicine and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact